# Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia

> **NCT07145775** · PHASE4 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 300 (actual)

## Conditions studied

- Epidural Analgesia
- Labor Pain
- Sufentanil
- Dexmedetomidine
- Esketamine
- Ropivacaine

## Interventions

- **DRUG:** sufentanil-ropivacaine combination
- **DRUG:** dexmedetomidine-esketamine-ropivacaine combination 1
- **DRUG:** dexmedetomidine-esketamine-ropivacaine combination 2

## Key facts

- **NCT ID:** NCT07145775
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-05
- **Primary completion:** 2026-01-29
- **Final completion:** 2026-03-13
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145775, "Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07145775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*